Summary
Introduction
Hereditary spastic paraparesis (HSP) may have autosomal dominant, recessive or X-linked inheritance and present in either pure or complicated forms. Pure HSP is characterized clinically by progressive spastic paraparesis and pathologically by degeneration of the corticospinal tracts and, to a lesser extent, the dorsal column and spinocerebellar tracts (Strümpell, 1880) . In complicated HSP other clinical features may include mental retardation, dementia, epilepsy, sensory neuropathy and pigmented retinal degeneration (Sutherland, 1975) . Although mental retardation is commonly associated with HSP, reports of associated dementia are rare and usually in autosomal recessive pedigrees (Bruyn, 1995) .
This division of HSP into pure and complicated forms may be artificial. There is evidence, on neurophysiological testing, of subclinical involvement of other tracts in the CNS in both forms (Dimitrijevic et al., 1982; Tedeschi et al., 1991; Durr et al., 1994) . Tedeschi et al. (1991) also demonstrated cognitive impairment in five out of seven patients with 'pure' HSP on neuropsychological testing.
© Oxford University Press 1998 unaffected, family controls showed no significant differences between the two groups. However, the neuropsychological test profile in four of 11 affected members tested (mean age 47.2 years) and one of 11 family controls (mean age 41.5 years) showed global cognitive impairment. The pattern of cognitive dysfunction was the same for all five family members identified and was similar to that found in subcortical dementia. The presence of cognitive impairment appeared to be related to age and not the severity of the paraplegia. Both the severity of the paraplegia and the age of onset (21-60 years) varied considerably in this family.
Families with autosomal dominant pure HSP have been linked to loci on chromosomes 2, 14 and 15 and at least one other locus is suspected (Hazan et al., 1993; Hazan et al., 1994; Bruyn et al., 1995; Fink et al., 1995) . The locus at chromosome 2p21-24 (SPG4) accounts for 40% of such families tested (Durr et al., 1996) . Genetic linkage studies in families with complicated HSP have not yet been reported.
In this study we report on a large Irish family initially thought to have pure autosomal dominant HSP, in whom some members, on neuropsychological testing, show evidence of global cognitive deficits with preservation of verbal function. Genetic linkage was established to the candidate region for pure HSP on chromosome 2 (SPG4).
Patients and methods Definitions
We used the criteria for a diagnosis of HSP as proposed by Fink et al. (1996) . Subjects are diagnosed as 'definitely affected' with HSP if (i) all alternative disorders have been excluded; (ii) the family history supports an inherited disorder; (iii) subjects report a progressive gait disturbance; and (iv) neurological examination shows a frank corticospinal tract deficit in the lower limbs, including grade 4 hyperreflexia and extensor plantar responses. 'Probably affected' subjects include asymptomatic individuals with lower limb hyper-reflexia and extensor plantar responses. 'Possibly affected' members are asymptomatic at-risk subjects who have a normal gait, but who show possible corticospinal tract deficits on examination (mild hyper-reflexia, a few beats of unsustained ankle clonus, but with flexor plantar responses). At-risk subjects are 'definitely unaffected' if they are asymptomatic, have a normal examination and are older than the maximal age of symptom onset in their family. 'Probably unaffected' subjects are asymptomatic, neurologically normal but younger than the maximal age of symptom onset in their family. Patients were not excluded if they had a minimal ataxia in the upper limbs, or distal muscle wasting of moderate degree so long as symptoms had been present for Ͼ10 years (Harding, 1981) .
Family
This study was approved by the ethics committee of St Vincent's Hospital and informed consent was obtained from all participating family members before inclusion in the study. For the purpose of confidentiality the family tree has been disguised (Fig. 1) .
There is information on 64 family members over four generations. All members of the first and second generation have died. Based on collateral history from at least two relatives, a great-grandfather in the first generation was probably affected and had four children including three affected daughters and one unaffected son. One of these daughters in the second generation had 14 children, 12 are still living and two are now dead. Of these 14 children, four are definitely affected and two (including one now dead) are probably affected. Twelve of the third generation had families with a total of 43 children. In the fourth generation there were four definitely and three probably affected members, all of whom had an affected parent.
Clinical assessment
Forty-four family members plus six spouses were interviewed and had full examinations by two neurologists. We used a five-point disability grading scale: 1 ϭ asymptomatic but definitely affected; 2 ϭ minimal disability; 3 ϭ requiring unilateral assistance; 4 ϭ requiring bilateral assistance; and 5 ϭ wheelchair bound.
Eleven affected members were screened for cognitive impairment using either the Short Test of Mental Status (STMS) (Kokmen et al., 1987) or the Cambridge Cognitive Examination (CAMCOG) (Roth et al., 1986) . Case III-6 was unavailable for examination.
Three of the affected members, III-4, IV-9 and IV-16, were fully investigated for spastic paraparesis. Tests included full blood count, electrolytes, liver function tests, glucose, blood urea and nitrogen, erythrocyte sedimentation rate, thyroid function tests, syphilis serology, HTLVI (human T-cell lymphocytotrophic virus), vitamin B 12 and folate, very long chain fatty acids, CSF including oligoclonal bands, visual evoked responses, neuro-imaging studies including CT of the brain, MRI of the brain and spinal cord or myelogram of the complete spinal cord.
Neuropsychological assessment
Eleven affected and eleven unaffected members matched for age, sex and years of education had neuropsychological assessment. Nine key categories of intellectual functioning were assessed. These included verbal IQ, performance IQ, verbal memory, visual memory, information processing speed, fine motor speed, verbal fluency, problem solving ability and perceptual judgement. Reading ability was also assessed.
The tests used and their order of presentation were as follows: (i) Schonell Graded Word Reading Test (Schonell and Goodacre, 1974) ; (ii) Fuld Object Memory Evaluation including Rapid Semantic Retrieval (Fuld, 1980) ; (iii) Symbol Digit Modalities (Smith, 1982) ; (iv) National Adult Reading Test (Nelson, 1982) ; (v) Selected subsets from the Wechsler Memory Scale-Revised (Logical Memory I and II, Figural Reproduction I and II) (Wechsler, 1987) ; (vi) Judgement of Line Orientation (Benton, 1983) ; (vii) Visual Form Discrimination (Benton, 1983) ; (viii) Purdue Pegboard (Tiffin, 1968) ; (ix) Wisconsin Card SortingTask (Heaton, 1981) ; and (x) Wechsler Adult Intelligence Scale-Revised (Wechsler, 1981) .
When assessing impaired performance, comparisons with published test norms were made. In the case of verbal and performance IQ, and verbal and visual memory, performance was considered impaired if it fell below the fifth percentile indicated in the test manuals when appropriate age adjustments were made. Performance on the Symbol Digit Modalities Test (information processing speed) was considered impaired if it fell -1.5 SD below the ageappropriate mean (Smith, 1982) . Verbal fluency was considered impaired when it fell -1.5 SD below the age norms provided by Fuld (1980) . Performance on the Purdue Pegboard (fine motor speed) was deemed impaired when it fell below the clinical cut-offs outlined in Lezak (1995) . On the Wisconsin Card Sorting Task (problem solving ability), Ͻ3.2 categories achieved was considered evidence of impairment (Milner, 1964) . Finally, scores below the clinical cut-offs as outlined by Benton et al. (1983) were used to determine deficit on tests of perceptual judgement (Judgement of Line Orientation cut-off ϭ 18; Visual Form Discrimination cut-off ϭ 25). With the exception of IQ categories, a category was failed if one or more tests within a given category was failed.
Genetic studies
Blood samples were taken from all family members and spouses examined. Polymorphic microsatellite markers spanning 20 cM and surrounding the SPG4 locus on chromosome 2p were analysed for linkage in this family. Pairwise lod scores were calculated with the M-LINK subprogram of the computer program LINKAGE (version 5.1), assuming equal recombination rates in males and females, a disease gene frequency of 0.0001 and age-dependent penetrance values, calculated based on age of onset of symptoms in the family (Terwilliger and Ott, 1994) . All participating family members were genotyped using nine polymorphic markers spanning the SPG4 locus. Complete details of the genetic studies have been submitted for publication elsewhere (P. Byrne, S. Webb, F. McSweeney, T. Burke, M. Hutchinson and N. Parfrey, personal communication).
Results

Clinical aspects of the family (Table 1)
There are 64 members over four generations. The pattern of inheritance is autosomal dominant with variable clinical 
expression and reduced penetrance. From 56 living members, 44 have been examined and of these 30 are Ͼ30 years of age. Eight family members (four in generation III and four in generation IV) were considered definitely affected with HSP and four asymptomatic members (one in generation III and three in generation IV) were considered probably affected. Five deceased members from the first to third generations were probably affected with HSP according to collateral history from at least two relatives. From hospital records, one member from the third generation suffered from senile dementia before she died aged 62 years.
Of 12 living members affected, five were in the third generation and seven were in the fourth generation. Seven affected members were male and five female. The mean age of onset in the third generation was 49.3 years with a range of 39-60 years and in the fourth generation it was 28.8 years, with a range of 21-38 years (based on those patients who were symptomatic). The average duration of illness was 17.3 years in the third generation and 11.3 years in the fourth generation. Increased difficulty walking and muscle spasms in the legs were common presenting features. All symptomatic patients had a markedly spastic gait, increased tone at rest, brisk reflexes, reduced vibration sensation and extensor plantar responses. Five had urinary dysfunction and three require intermittent or permanent urinary catheterization. One had impotence. All had normal cranial nerves and upper limb examination, except for brisk reflexes in four and a pronator catch in three. In the third generation there was one asymptomatic member, aged Ͼ60 years, and two patients required bilateral and two unilateral assistance. In the fourth generation there were three asymptomatic members, aged between 30 and 40 years, two others required unilateral assistance and two had minimal disability. Two affected members have a history of psychosis. Family member III-8 who developed HSP at the age of 58 years has been an inpatient of a psychiatric hospital for 43 years with 'chronic schizophrenia' and IV-2 developed paranoid schizophrenia at 21 years of age simultaneously with the onset of HSP.
Case report Case III-4
This 69-year-old man first noticed progressive difficulty walking at 40 years of age and was thought to have multiple sclerosis at that time. At 55 years he used a stick and at 62 years he was confined indoors and walked only with the aid of a frame. He also complained of increasing urinary incontinence and now has an in-dwelling urinary catheter. On examination he had normal cranial nerves, mild wasting of the small muscles of both hands and brisk reflexes in the arms and legs. His legs also had marked spasticity, reduced power in a pyramidal distribution and extensor plantar responses. Vibration and proprioception were reduced bilaterally. He walked only a few steps using a frame. He was noted to have difficulty in finding his way back to the room in the ward and had marked construction difficulties in drawing a clock (see also Fig. 2 ). His STMS score was 23 out of 38.
Neuropsychological investigations
Affected family members and unaffected family controls, matched for age, sex and number of years in education, showed no difference in reading ability (mean reading age 11.62 Ϯ 2.68 and 12.12 Ϯ 1.89 years, respectively). Hand function was normal in all members of both groups.
Four affected members from the older generation (III-2, III-4, III-7 and III-8) and one unaffected member from the older generation (III-12) had abnormal scores in STMS and/ or CAMCOG at screening, suggesting the presence of a dementia (see Table 2 ). All other family members were considered normal at this stage.
Neuropsychological tests were performed on both affected and unaffected groups to characterize the type of cognitive impairment identified at screening. No significant differences were found between the two groups when performance was compared across all neuropsychological tests (Table 3) . In all cases, α was set at 0.01 in order to guard against Type 1 error. However, this is a relatively low functioning family, the mean full scale IQ in both groups falls within the low average range. In addition, comparisons of small groups can mask extreme performances.
Nine key categories of intellectual functioning were evaluated in both affected (Table 4 ) and unaffected groups (Table 5) . Failure on over half the categories administered was used, as a conservative cut-off, to identify those patients showing evidence of a global cognitive impairment. All four affected members of the older generation showed impaired performance across a wide range of intellectual functions. One member failed seven of nine categories, another failed six of eight categories and two failed five and four of seven categories. It was not possible to assess all nine categories in some members of the older generation. This global pattern of impairment is not evident in the affected members of the younger generation.
One member of the unaffected group (III-12) also failed six of nine categories, demonstrating a similar pattern of global impairment (Table 4 ). This woman was aged 57 years at the time of testing and did not show any evidence of a spastic paraparesis on repeated testing.
The cognitive deficit observed is characterized by impaired performance on visuospatial tasks, memory tasks, and tasks of fine motor speed and information processing speed.
Genetic results
DNA was obtained from 44 family members and six spouses for genetic linkage analysis. There were eight family members definitely affected with HSP and four asymptomatic but probably affected members. Genetic linkage analysis was initially performed for a phenotype of spastic paraparesis. For this analysis, 12 members were considered to be affected (eight with definite HSP and four with probable HSP). Evidence of linkage to the SPG4 locus on chromosome 2p was obtained with a maximum lod score of 2.86, θ ϭ 0.00, for D2S2374. The genotype data was reanalysed for a phenotype of spastic paraparesis and/or cognitive impairment. For this analysis, 13 members were considered to be affected [eight with definite HSP and four with probable HSP (four of whom had cognitive impairment) and one other member (III-12) who had cognitive impairment but no signs of paraparesis]. Significant evidence of linkage, with this phenotype, to chromosome 2p was obtained (lod score 3.86, at θ ϭ 0.00 for D2S2374). Positive lod scores were also obtained for the six remaining markers in this region of chromosome 2. Genetic analysis was also performed for a phenotype of spastic paraparesis with or without cognitive impairment assuming an unknown status for III-12 (maximum lod score 3.52, at θ ϭ 0.00, for D2S2374). Multipoint linkage analysis confirmed the disease gene was most tightly linked to D2S2374. Analysis of the resulting genotype data revealed a core haplotype that was present in all 13 family members affected with spastic paraparesis and/or cognitive impairment.
Discussion
In this family with HSP, neuropsychological examination demonstrated the presence of global cognitive impairment in four affected members, III-2, III-4, III-7 and III-8. In the unaffected group only III-12 showed similar impairment with a pattern of deficit identical to the other four cases. The presence of HSP and cognitive impairment in this family may be coincidental. It may, however, be due to an inherited single gene disorder with a variably expressed phenotype of HSP and cognitive impairment or it is possible that two genes for HSP and dementia are closely linked at this locus. In support of a non-coincidental association, neuropsychological tests showed significant cognitive impairment in all four affected members of the older generation and III-12 had an identical pattern of cognitive impairment which may be the only evidence of the abnormal gene(s). Both the age of onset and severity of HSP show considerable variation within this family, an observation which has previously been reported for HSP (Burdick et al., 1981; Polo et al., 1993) . Variable expression is also commonly reported in other autosomal dominant neurological conditions, e.g. Huntington's disease (Farrer and Conneally, 1987) , Machado Joseph disease (Rosenberg, 1992) and tuberous sclerosis (Northrup, 1992) . In this family the agedependent lod scores were calculated considering a phenotype of HSP alone, a phenotype of HSP alone, with an unknown affected status for III-12 and a phenotype of HSP and/or cognitive impairment. In each analysis, evidence of linkage to chromosome 2 was shown. Using the phenotype of HSP alone a maximum lod score of 2.86 was calculated for D2S2374 and this increased to 3.52 when the affected status of III-12 was considered unknown. The combined phenotype of HSP and/or cognitive impairment resulted in lod scores for all chromosome 2 markers that were higher than those previously obtained under the phenotype of spastic paraparesis alone (a maximum lod score of 3.86 was obtained for D2S2374). Haplotype analysis confirmed the affected status of all 13 members with HSP and/or cognitive impairment [eight with definite HSP and four with probable HSP, four of whom had cognitive impairment, and one other member (III-12) who had cognitive impairment but no signs of paraparesis].
Impaired performance across a wide range of cognitive functions in the presence of adequate verbal tests suggests dementia rather than mental retardation as the cause of those deficits. However, dementia refers to the deterioration of previously acquired intellectual abilities in an alert patient with normal arousal and must be sufficiently severe to interfere with social and occupational function (American Psychiatric Association, 1994) . In the absence of longitudinal testing in this family, we lack conclusive evidence of progressive deterioration in cognitive function. The generally low reading level of this family also mitigates against the effectiveness of traditional tests for estimating premorbid ability levels, such as the National Adult Reading Task. The presence of widespread cognitive impairment in the affected members of the older generation and the general lack of impairment in the younger generation suggests a progressive course, with an age-related fall in performance. In keeping with this, one member is reported to have died with progressive spastic paraparesis and dementia. These patients probably remain asymptomatic for dementia because of limitations imposed by their spastic paraparesis; all but the least affected are largely confined to the familiar and protective environment of the home. Case III-7, who is asymptomatic for both dementia and HSP, is not regularly subjected to new social or occupational tasks which might otherwise make her dementia more clinically obvious. The pattern of cognitive impairment in this family does not fit completely into any previously recognized form of dementia. Dementia of Alzheimer's type, frontal lobe type, Lewy body type, Parkinson's disease and subcortical dementias are all characterized by poor performance on tasks of verbal fluency. Cognitively impaired members of this family demonstrate normal performance on such tasks. The pattern of impaired performance, slowness of information processing, forgetfulness, difficulty in shifting mental set, together with the general absence of aphasia, agnosia and acalculia most closely resembles that of a subcortical dementia.
The finding of cognitive loss in HSP might not be unexpected, as it has been seen with varying frequency in other neurodegenerative diseases with motor system dysfunction including Parkinson's, progressive supranuclear palsy, spinocerebellar degeneration and motor neuron disease (Cummings, 1986; Neary et al., 1990) The association of spastic paraparesis with mental retardation is relatively common, but reports with dementia are rare and show considerable heterogeneity. Twelve families with HSP and dementia have been identified from the literature and, of these, 11 had autosomal recessive and one autosomal dominant inheritance (Rhein, 1916; Manson, 1920; Worster-Drought, 1940 , Worster-Drought, 1944 Heuyer, 1952; Ledic and Van Bobaert, 1960; Cross and McKusick, 1967b; Arjundas et al., 1971; Sutherland, 1975; Rothner et al., 1976; Sjasstad et al., 1976; Farmer et al., 1985; D' Hooghe, 1992; Ferrer et al., 1995) . Other clinical features were often reported and included ataxia, dysarthria, athetosis, macular pigmentation and optic atrophy. Only two families had HSP and dementia alone, both with autosomal recessive inheritance. Although the onset of symptoms and the presence or absence of other clinical features may vary widely between families there is little variation within families. An epidemiological study of HSP in western Norway recorded dementia in nine out of 34 cases with HSP and suggested that dementia was more common in autosomal recessive pedigrees (Skre, 1974) . Recently a variant of Gerstmann-Sträussler-Scheinker disease, described in four unrelated Japanese families and characterized by dementia, spastic paraparesis, ataxia and dysarthria has been linked to a missense mutation at codon 5 and codon 129 polymorphism on the PrP gene (Itoh et al., 1994 ). Yet, spastic paraparesis and dementia alone may be the only clinical features of this mutation (Kitamoto et al., 1993) .
When comparing the impairments found in this family with those found in other reports of dementia and HSP, one finds similarities between the areas of cognition that are affected. Arjundas (1971) described cognitive changes that include poor perceptual speed and spatial perception, poor recent memory and poorer than normal visuomotor coordination in two of the patients studied. Other investigators found disorders of attention, trouble in planning and carrying out new tasks and defective recent memory (Ferrer et al., 1995) . The same report also evaluated neuropathological data from the same sample and noted cerebral and subcortical white matter abnormalities, together with atrophy of the thalamic dorsomedial complex. They concluded that these changes were responsible for the dementia observed (Ferrer et al., 1995) . The only report of autosomal dominant HSP with dementia, by Rothner et al. (1976) , did not provide detail of the areas of cognition affected. Nonetheless, there are enough similarities between previously recorded impairments and the impairments seen in the current sample to suggest that there may be a characteristic form of dementia associated with HSP.
To date, there is only one study of cognitive impairment in 'pure' HSP. Tedeschi et al. (1991) reported seven patients from four families with both dominant and recessive HSP (aged 27-53 years). The oldest patient (53 years) had clinical evidence of cognitive impairment and five patients in total were shown to have cognitive impairment using a mental deterioration battery. The deficit in all of these patients, like the affected members of our family, was asymptomatic and never interfered with normal schooling or daily activities. Perhaps the true incidence of dementia in association with 'pure' HSP is not reflected in the clinical literature because it is not prominent and because in many cases it has not been sought. Based on our findings we suggest that some consideration should be given to the possible presence of asymptomatic dementia in all family members with HSP. This has obvious consequences for the patients, for accurate classification, for genetic counselling and for genetic linkage studies which rely on accurate diagnosis of all affected members for successful analysis.
Several authors now dispute the idea of 'pure' HSP and suggest a multi-system involvement of the CNS in many patients with 'pure' HSP but with varying clinical and subclinical expression (Tedeschi et al., 1991; Dürr et al., 1994; Dimitrijevic et al., 1982) . The finding of cognitive impairment in our family would support this concept. Genetic studies in this family have shown linkage to chromosome 2p, in the same region as that reported for pure autosomal dominant HSP. This observation suggests close proximity of two genes for pure and complicated HSP or close proximity of a gene for pure HSP and a gene for dementia or a single gene disorder with allelic heterogeneity or variable phenotypic expression. Further studies are required to determine the underlying genetic abnormality.
